Citigroup Initiates Coverage On Nuvation Bio with Buy Rating, Announces Price Target of $12

Benzinga · 1d ago
Citigroup analyst Geoff Meacham initiates coverage on Nuvation Bio (NYSE:NUVB) with a Buy rating and announces Price Target of $12.